Preparing an oncolytic poliovirus recombinant for clinical application against glioblastoma multiforme
- 17 March 2010
- journal article
- review article
- Published by Elsevier in Cytokine & Growth Factor Reviews
- Vol. 21 (2-3) , 197-203
- https://doi.org/10.1016/j.cytogfr.2010.02.005
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Direct functional interaction of initiation factor eIF4G with type 1 internal ribosomal entry sitesProceedings of the National Academy of Sciences, 2009
- Evaluation of IRES-mediated, cell-type-specific cytotoxicity of poliovirus using a colorimetric cell proliferation assayJournal of Virological Methods, 2008
- Recombinant Oncolytic Poliovirus Eliminates Glioma In Vivo Without Genetic Adaptation to a Pathogenic PhenotypeMolecular Therapy, 2008
- Activation of cap-independent translation by variant eukaryotic initiation factor 4G in vivoRNA, 2008
- Virus therapy of human cancersMelanoma Research, 2003
- Does phosphorylation of the cap‐binding protein eIF4E play a role in translation initiation?European Journal of Biochemistry, 2002
- Expression of the Human Poliovirus Receptor/CD155 Gene Is Activated by Sonic HedgehogPublished by Elsevier ,2002
- Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cellsThe FASEB Journal, 2002
- Nectin4/PRR4, a New Afadin-associated Member of the Nectin Family That Trans-interacts with Nectin1/PRR1 through V Domain InteractionJournal of Biological Chemistry, 2001
- Attenuated, Replication-Competent Herpes Simplex Virus Type 1 Mutant G207: Safety Evaluation of Intracerebral Injection in Nonhuman PrimatesJournal of Virology, 1999